The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody ObinutuzumabAlicja Kuzniewska,Alan Majeranowski, Sara Henry,Daria Kowalska,Grzegorz Stasilojc,Aleksandra Urban,Jan M. Zaucha,Marcin OkrojCANCERS(2024)引用 0|浏览31暂无评分关键词complement system,rituximab,obinutuzumabAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要